Changhai Hospital

This early-phase study tests a new treatment called KN3601, which uses specially engineered immune cells (CAR T cells) to target and destroy faulty B cells that attack the kidneys. The goal is to see if it is safe and can control disease in 36 adults with relapsed or refractory i…

This study tests a new approach to treat high-risk bladder cancer without removing the bladder. It combines freezing the tumor during surgery, immunotherapy, and low-dose chemotherapy. The goal is to see if this combo can help patients live longer and keep their bladder, compared…

This study tests whether transplanting healthy gut bacteria (FMT) can reduce serious complications like infections in people with moderate to severe acute pancreatitis. About 80 adults will receive either FMT or a placebo, and researchers will track infection rates and recovery. …

This study tests a drug called hetrombopag to prevent low platelet counts caused by chemotherapy in people with gastrointestinal tumors (like stomach or colon cancer). About 40 patients will take the drug daily for 14 days after each chemo cycle. The goal is to see if it keeps pl…

This study tests whether adding the immunotherapy drug toripalimab to standard BCG treatment can stop high-risk bladder cancer from coming back after surgery. About 31 adults with a serious type of bladder cancer will receive the combination for 6 months. The goal is to see if th…

This study tests an artificial intelligence (AI) system that helps doctors diagnose pancreatic diseases using contrast-enhanced CT scans. The AI compares its recommendations with those of experienced doctors to see if it can accurately classify patients into treatment, close moni…

This study tests whether fecal microbiota transplantation (FMT) can prevent serious infections in people with moderately severe or severe acute pancreatitis. About 150 adults aged 18-75 who are in the later phase of the disease will receive FMT or a placebo through a feeding tube…

This study tests whether giving extra fluids through a vein along with a standard anti-inflammatory drug (indometacin) can better prevent pancreatitis after a procedure that breaks up pancreatic stones (ESWL). About 1250 adults with painful chronic pancreatitis will be randomly a…

This study tests whether a pre-packaged low-residue diet (Maifu Changqing® Complete Nutrition Formula Powder) helps people with inflammatory bowel disease (IBD) prepare for a colonoscopy more comfortably and with better nutrition. About 1,000 adults with IBD will be randomly assi…